Evidence map›Paper›PMID 22584413›Full record

ArticleEuropean journal of nutrition2013

Antiplatelet effect of new lipophilic hydroxytyrosol alkyl ether derivatives in human blood.

J J Reyes, J P De La Cruz, J Muñoz-Marin, A Guerrero, J A Lopez-Villodres, A Madrona, J L Espartero, J A Gonzalez-Correa

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

J J ReyesEscuela Universitaria Ciencias de la Salud, University of Málaga, Malaga, Spain.
J P De La Cruz
J Muñoz-Marin
A Guerrero
J A Lopez-Villodres
A Madrona
J L Espartero
J A Gonzalez-Correa
Universidad de Málaga · ESUniversidad de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the in vitro antiplatelet and anti-inflammatory effects of five alkyl hydroxytyrosol (HT) ether derivatives in human whole blood and compare these effects with those of HT.

methodsBlood samples from healthy volunteers were incubated with HT and HT alkyl ether derivatives (ethyl, butyl, hexyl, octyl and dodecyl). Maximum intensity of platelet aggregation was induced with collagen, arachidonic acid or ADP. Calcium-induced thromboxane B(2) and nitric oxide production, LPS-induced prostaglandin E(2) and nitric oxide production and LPS-induced interleukin 1β production were measured.

resultsAll compounds inhibited platelet aggregation, thromboxane B(2) and inflammatory mediators in a concentration-dependent manner. The concentrations of each compound that inhibited the corresponding variable by 50 % compared to control samples (IC(50)) were in the range of 10(-7)-10(-6) M for HT hexyl ether; for the other compounds, these values were in the range of 10(-5) M. The IC(50) for thromboxane B(2) production was in the range of 10(-4) M. The effects of HT alkyl ether derivatives were greater than those of HT. These compounds increased nitric oxide production. There was no direct relationship between the effects of these compounds and alkyl chain length. Maximum effects were observed in the C4-C6 range.

conclusionsAlkyl ether derivatives of HT exert antiplatelet and anti-inflammatory effects that are greater than those of HT.

Indexed as

AdultAnti-Inflammatory AgentsDinoprostoneEtherFemaleHumansInflammationInterleukin-1betaMaleNitric OxidePhenylethyl AlcoholPlatelet AggregationPlatelet Aggregation InhibitorsThromboxane B23,4-dihydroxyphenylethanolAnti-Inflammatory AgentsDinoprostoneEtherInterleukin-1betaNitric OxidePhenylethyl AlcoholPlatelet Aggregation InhibitorsThromboxane B2

Identifiers

PMID22584413
OpenAlexW1990650750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.